Replimune Group, Inc. (REPL)
NASDAQ: REPL · IEX Real-Time Price · USD
9.66
-0.23 (-2.33%)
Jul 22, 2024, 10:07 AM EDT - Market open
Replimune Group Employees
Replimune Group had 331 employees as of March 31, 2024. The number of employees increased by 47 or 16.55% compared to the previous year.
Employees
331
Change (1Y)
47
Growth (1Y)
16.55%
Revenue / Employee
n/a
Profits / Employee
-$651,946
Market Cap
595.11M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ZimVie | 2,600 |
Ginkgo Bioworks Holdings | 1,218 |
Adaptive Biotechnologies | 709 |
REGENXBIO | 344 |
ProKidney | 163 |
KalVista Pharmaceuticals | 150 |
Astria Therapeutics | 59 |
Celcuity | 55 |
REPL News
- 6 weeks ago - Replimune to Present at the Goldman Sachs 45th Annual Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Replimune Announces Positive Topline Primary Analysis Data by Independent Central Review from IGNYTE Clinical Trial of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma - GlobeNewsWire
- 7 weeks ago - Replimune Presents Positive Data from RP1 and RP2 Clinical Programs at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 2 months ago - Replimune to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting - GlobeNewsWire
- 2 months ago - Replimune Reports Fiscal Fourth Quarter and Year Ended 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 3 months ago - Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) 2024 Annual Meeting - GlobeNewsWire
- 3 months ago - Replimune Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 months ago - Replimune Announces Appointment of Sushil Patel to CEO and Executive Leadership Transitions - GlobeNewsWire